MONTPELLIER, France (BUSINESS WIRE) Regulatory News:MedinCell (Paris:MEDCL):During today’s Q2 earnings call, Richard Francis, President and CEO of Teva, and Eric Hughes, Executive Vice President, Global R&D & Chief Medical Officer, commented the US launch of UZEDY since May 2023 and the olanzapine Long-Acting Inje.
MedinCell s Partner Teva Announces Successful Launch of UZEDY finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.